Lam Research Co. Expected to Post Q1 2026 Earnings of $9.08 Per Share (NASDAQ:LRCX)

Lam Research Co. (NASDAQ:LRCXFree Report) – Analysts at Zacks Research upped their Q1 2026 earnings per share (EPS) estimates for Lam Research in a research report issued on Thursday, April 18th. Zacks Research analyst R. Department now anticipates that the semiconductor company will post earnings per share of $9.08 for the quarter, up from their prior estimate of $9.02. The consensus estimate for Lam Research’s current full-year earnings is $28.92 per share. Zacks Research also issued estimates for Lam Research’s Q2 2026 earnings at $9.94 EPS.

A number of other equities analysts have also commented on the company. Deutsche Bank Aktiengesellschaft began coverage on Lam Research in a research note on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price objective on the stock. The Goldman Sachs Group boosted their price target on Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Citigroup increased their price objective on shares of Lam Research from $800.00 to $975.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. Evercore ISI began coverage on Lam Research in a report on Tuesday, April 16th. They set an “outperform” rating and a $1,200.00 price objective on the stock. Finally, Needham & Company LLC upped their target price on Lam Research from $900.00 to $1,030.00 and gave the stock a “buy” rating in a report on Thursday. Seven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $931.85.

Check Out Our Latest Analysis on Lam Research

Lam Research Stock Performance

Shares of NASDAQ:LRCX opened at $870.25 on Monday. The company has a quick ratio of 2.02, a current ratio of 3.06 and a debt-to-equity ratio of 0.61. Lam Research has a 12-month low of $493.42 and a 12-month high of $1,007.39. The company’s 50 day moving average price is $945.44 and its two-hundred day moving average price is $802.29. The firm has a market cap of $114.09 billion, a PE ratio of 33.65, a PEG ratio of 3.15 and a beta of 1.51.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The company had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the previous year, the business posted $10.71 earnings per share. Lam Research’s quarterly revenue was down 28.8% on a year-over-year basis.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were paid a $2.00 dividend. This represents a $8.00 annualized dividend and a dividend yield of 0.92%. The ex-dividend date of this dividend was Tuesday, March 12th. Lam Research’s dividend payout ratio (DPR) is presently 30.94%.

Insider Activity

In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of Lam Research stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the completion of the sale, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $857,330.46. Following the completion of the transaction, the director now directly owns 10,541 shares in the company, valued at approximately $10,246,168.23. The disclosure for this sale can be found here. Insiders have sold 7,029 shares of company stock worth $6,559,489 over the last 90 days. 0.32% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Lam Research

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Orion Capital Management LLC bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $25,000. Hobbs Group Advisors LLC purchased a new stake in Lam Research in the fourth quarter worth $27,000. BluePath Capital Management LLC bought a new stake in shares of Lam Research in the third quarter valued at $28,000. DSM Capital Partners LLC purchased a new position in shares of Lam Research during the 4th quarter valued at $28,000. Finally, OFI Invest Asset Management bought a new position in shares of Lam Research during the 3rd quarter worth $30,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

See Also

Earnings History and Estimates for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.